Regensburg. Luca Gattinoni and Matthias Edinger from the Leibniz Institute for Immunotherapy (LIT) and Regensburg University Hospital (UKR) have received a grant of 2.6 million euros from the German Cancer Aid. An innovative clinical study that uses stem cell-like CAR-T cells to treat patients with advanced lymphoma is being funded. The University of Regensburg reports this in a press release.
Aggressive lymphomas are cancers of the lymphatic tissue that cause life-threatening diseases. During chemotherapy some patients…